InvestorsHub Logo
icon url

riskforprofit

02/28/13 2:42 PM

#35251 RE: riskforprofit #35250

Please make your own call when it comes to investing in EPGL. I believethis is going to be huge. If the government makes the MPDD a mandatory instrument in fighting the war on back pain for all the disability claims, this stock will be at $4-$5 per share[/i].for real

Think of all the fake claims every year because of "muscle pain " or "a pulled muscle in the back or leg".

Until now, there has been no way to detect that pain. Fake back pain is a big part of the problem with the war on drugs. Thats what the MPDD is for. It actually detects which muscle is hurting and pulled or ripped. It can also detect it if there is NO INJURY. No more fake disability claims

That means every doctor in America will be using it to detect muscle pain. It is for every muscle in the body, not just the back.
icon url

wobblenuts

02/28/13 2:46 PM

#35252 RE: riskforprofit #35250

MPTT does not have 510k yet. I think this was covered in latest tweet session. September timeframe, I recall.

MPDD&MPTT will fund BIOMEMS developement to market and support overhead, IMO.

Company has stated in past they have the funds to operate thru '13
regardless of MPDD&MPTT income. Therefor, no dilution, also stated by company.

EPGL
icon url

H8ster

02/28/13 2:47 PM

#35253 RE: riskforprofit #35250

Did you not read the PR from Monday?

...the MPTT (Muscle Pain Trigger-Point Treatment) is being put on a track to be released by December, 2013 pending FDA 510k approval. The MPTT FDA 510k approval is expected by September, 2013. At least two other FDA 510k applications will be pending and the Company is optimistic those will be approved in the same approximate time frame.


www.prweb.com/releases/2013/2/prweb10464659.htm